Home|Journals|Articles by Year|Audio Abstracts
 

Case Report

EJMCR. 2020; 4(12): 432-435


Detection of SARS CoV-2 RNA in pericardial effusion in a patient with cardiac tamponade - a rare case report

Elena Falchetti, Matteo Francioni, Maria Vittoria Matassini, Stefano Menzo, Laura Morbidoni, Gianfranco Maracchini, Antonio Mariani, Gian Piero Perna.




Abstract
Cited by 1 Articles

Background: Coronavirus disease 2019 (COVID-19) infection can involve the cardiovascular system with many presentations, including pericardial effusion. Nevertheless, there is no evidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA detected in pericardial effusion during the acute phase of COVID-19 infection.
Case Presentation: We report an acute, large but located pericardial effusion during acute COVID-19 infection, which required emergent pericardiocentesis. SARS-CoV-2 RNA was found in the pericardial fluid. The patient also presented with concomitant pleural and peritoneal effusion. The patient was treated with colchicine and was discharged 16 days later.
Conclusion: SARS-CoV-2 RNA can be detected in pericardial effusion during the acute phase of COVID-19 infection. Concomitant presence of pleural and peritoneal effusion could confirm the hypothesis of exaggerated systemic inflammatory response triggered by the virus.

Key words: COVID-19, cardiac tamponade, pericardial effusion, polyserositis






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.